Javelin Pharmaceuticals, Inc. v. Mylan Laboratories Limited
1:16-cv-00224
Overview
Parties
Defendant
Mylan Laboratories Limited NPE (University / Research)
Represented By
4 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Mylan Pharmaceuticals Inc. Operating Company
Represented By
4 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Plaintiff
Javelin Pharmaceuticals, Inc. Operating Company
Represented By
5 Attorneys ListedConnolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Janssen Pharmaceutica N.V. NPE (Individual / Inventor)
Represented By
5 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Counter Claimant
Hospira, Inc. Operating Company
Represented By
5 Attorneys ListedConnolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Mylan Inc. Operating Company
Represented By
5 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Janssen Pharmaceutica N.V. v. Xellia Pharmaceuticals ApS
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6407079
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
|
Filed: 1988-10-31
Issued: 2002-06-18
|
Expired (Term Ended)
Expires: 2008-10-31
|
|
|
US8946292
Formulations of low dose diclofenac and beta-cyclodextrin
|
Filed: 2011-05-12
Issued: 2015-02-03
|
Active (4.5 yrs remaining)
Expires: 2031-05-12
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
36
Dispositive
14
Granted
0
Denied
2
Pending / Review
27
Motions by Category
Key Dispositive Motions & Rulings